Abstract
Human pluripotent stem cells (PSCs) have the potential to provide a virtually unlimited supply of cells for transplantation therapy. When combined with recent advances in genome editing technologies, human PSCs could offer various approaches that enable gene therapy, drug discovery, disease modeling, and in vitro modeling of human development. De novo generation of hematopoietic stem cells (HSCs) from human PSCs is an important focus in the field, since it enables autologous HSC transplantation to treat many blood disorders and malignancies. Although culture conditions have been established to generate a broad spectrum of hematopoietic progenitors from human PSCs, it remains a significant challenge to generate bona fide HSCs that possess sustained self-renewal and multilineage differentiation capacities upon transplantation. In this review, recent promising advances in the efforts to generate HSCs and hematopoietic progenitors from human PSCs in vitro and in vivo or from somatic cells are discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Orkin SH, Zon LI (2008) Hematopoiesis: an evolving paradigm for stem cell biology. Cell 132(4):631–644
Niederwieser D, Baldomero H, Szer J, Gratwohl M, Aljurf M, Atsuta Y et al (2016) Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey. Bone Marrow Transplant 51(6):778–785
Giralt S, Costa L, Schriber J, Dipersio J, Maziarz R, McCarty J et al (2014) Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendations. Biol Blood Marrow Transplant 20(3):295–308
Kumar S, Geiger H (2017) HSC niche biology and hsc expansion ex vivo. Trends Mol Med 23(9):799–819
Palis J, Robertson S, Kennedy M, Wall C, Keller G (1999) Development of erythroid and myeloid progenitors in the yolk sac and embryo proper of the mouse. Development 126(22):5073–5084
Gomez Perdiguero E, Klapproth K, Schulz C, Busch K, Azzoni E, Crozet L et al (2015) Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors. Nature 518(7540):547–551
McGrath KE, Frame JM, Fegan KH, Bowen JR, Conway SJ, Catherman SC et al (2015) Distinct sources of hematopoietic progenitors emerge before HSCs and provide functional blood cells in the mammalian embryo. Cell Rep 11(12):1892–1904
Boiers C, Carrelha J, Lutteropp M, Luc S, Green JC, Azzoni E et al (2013) Lymphomyeloid contribution of an immune-restricted progenitor emerging prior to definitive hematopoietic stem cells. Cell Stem Cell 13(5):535–548
Medvinsky A, Dzierzak E (1996) Definitive hematopoiesis is autonomously initiated by the AGM region. Cell 86(6):897–906
de Bruijn MF, Ma X, Robin C, Ottersbach K, Sanchez MJ, Dzierzak E (2002) Hematopoietic stem cells localize to the endothelial cell layer in the midgestation mouse aorta. Immunity 16(5):673–683
de Bruijn MF, Speck NA, Peeters MC, Dzierzak E (2000) Definitive hematopoietic stem cells first develop within the major arterial regions of the mouse embryo. EMBO J 19(11):2465–2474
Ottersbach K, Dzierzak E (2005) The murine placenta contains hematopoietic stem cells within the vascular labyrinth region. Dev Cell 8(3):377–387
Li Z, Lan Y, He W, Chen D, Wang J, Zhou F et al (2012) Mouse embryonic head as a site for hematopoietic stem cell development. Cell Stem Cell 11(5):663–675
Gekas C, Dieterlen-Lievre F, Orkin SH, Mikkola HK (2005) The placenta is a niche for hematopoietic stem cells. Dev Cell 8(3):365–375
Kaufman DS, Hanson ET, Lewis RL, Auerbach R, Thomson JA (2001) Hematopoietic colony-forming cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A 98(19):10716–10721
Nakano T, Kodama H, Honjo T (1994) Generation of lymphohematopoietic cells from embryonic stem cells in culture. Science 265(5175):1098–1101
Vodyanik MA, Bork JA, Thomson JA, Slukvin II (2005) Human embryonic stem cell-derived CD34+ cells: efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential. Blood 105(2):617–626
Itskovitz-Eldor J, Schuldiner M, Karsenti D, Eden A, Yanuka O, Amit M et al (2000) Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol Med 6(2):88–95
Chadwick K, Wang L, Li L, Menendez P, Murdoch B, Rouleau A et al (2003) Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells. Blood 102(3):906–915
Cerdan C, Rouleau A, Bhatia M (2004) VEGF-A165 augments erythropoietic development from human embryonic stem cells. Blood 103(7):2504–2512
Pick M, Azzola L, Mossman A, Stanley EG, Elefanty AG (2007) Differentiation of human embryonic stem cells in serum-free medium reveals distinct roles for bone morphogenetic protein 4, vascular endothelial growth factor, stem cell factor, and fibroblast growth factor 2 in hematopoiesis. Stem Cells 25(9):2206–2214
Galic Z, Kitchen SG, Kacena A, Subramanian A, Burke B, Cortado R et al (2006) T lineage differentiation from human embryonic stem cells. Proc Natl Acad Sci U S A 103(31):11742–11747
Schmitt TM, Zuniga-Pflucker JC (2002) Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro. Immunity 17(6):749–756
Timmermans F, Velghe I, Vanwalleghem L, De Smedt M, Van Coppernolle S, Taghon T et al (2009) Generation of T cells from human embryonic stem cell-derived hematopoietic zones. J Immunol 182(11):6879–6888
Ramos-Mejia V, Melen GJ, Sanchez L, Gutierrez-Aranda I, Ligero G, Cortes JL et al (2010) Nodal/Activin signaling predicts human pluripotent stem cell lines prone to differentiate toward the hematopoietic lineage. Mol Ther 18(12):2173–2181
Inman GJ, Nicolas FJ, Callahan JF, Harling JD, Gaster LM, Reith AD et al (2002) SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol 62(1):65–74
Kennedy M, Awong G, Sturgeon CM, Ditadi A, LaMotte-Mohs R, Zuniga-Pflucker JC et al (2012) T lymphocyte potential marks the emergence of definitive hematopoietic progenitors in human pluripotent stem cell differentiation cultures. Cell Rep 2(6):1722–1735
Woll PS, Morris JK, Painschab MS, Marcus RK, Kohn AD, Biechele TL et al (2008) Wnt signaling promotes hematoendothelial cell development from human embryonic stem cells. Blood 111(1):122–131
Wang Y, Nakayama N (2009) WNT and BMP signaling are both required for hematopoietic cell development from human ES cells. Stem Cell Res 3(2-3):113–125
Sturgeon CM, Ditadi A, Awong G, Kennedy M, Keller G (2014) Wnt signaling controls the specification of definitive and primitive hematopoiesis from human pluripotent stem cells. Nat Biotechnol 32(6):554–561
Choi KD, Vodyanik MA, Togarrati PP, Suknuntha K, Kumar A, Samarjeet F et al (2012) Identification of the hemogenic endothelial progenitor and its direct precursor in human pluripotent stem cell differentiation cultures. Cell Rep 2(3):553–567
Ditadi A, Sturgeon CM, Tober J, Awong G, Kennedy M, Yzaguirre AD et al (2015) Human definitive haemogenic endothelium and arterial vascular endothelium represent distinct lineages. Nat Cell Biol 17(5):580–591
Ackermann M, Liebhaber S, Klusmann JH, Lachmann N (2015) Lost in translation: pluripotent stem cell-derived hematopoiesis. EMBO Mol Med 7(11):1388–1402
Tian X, Woll PS, Morris JK, Linehan JL, Kaufman DS (2006) Hematopoietic engraftment of human embryonic stem cell-derived cells is regulated by recipient innate immunity. Stem Cells 24(5):1370–1380
Ledran MH, Krassowska A, Armstrong L, Dimmick I, Renstrom J, Lang R et al (2008) Efficient hematopoietic differentiation of human embryonic stem cells on stromal cells derived from hematopoietic niches. Cell Stem Cell 3(1):85–98
Shultz LD, Lyons BL, Burzenski LM, Gott B, Chen X, Chaleff S et al (2005) Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J Immunol 174(10):6477–6489
Lu M, Kardel MD, O'Connor MD, Eaves CJ (2009) Enhanced generation of hematopoietic cells from human hepatocarcinoma cell-stimulated human embryonic and induced pluripotent stem cells. Exp Hematol 37(8):924–936
Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, Hioki K et al (2002) NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood 100(9):3175–3182
Sauvageau G, Lansdorp PM, Eaves CJ, Hogge DE, Dragowska WH, Reid DS et al (1994) Differential expression of homeobox genes in functionally distinct CD34+ subpopulations of human bone marrow cells. Proc Natl Acad Sci U S A 91(25):12223–12227
Antonchuk J, Sauvageau G, Humphries RK (2002) HOXB4-induced expansion of adult hematopoietic stem cells ex vivo. Cell 109(1):39–45
Kyba M, Perlingeiro RC, Daley GQ (2002) HoxB4 confers definitive lymphoid-myeloid engraftment potential on embryonic stem cell and yolk sac hematopoietic progenitors. Cell 109(1):29–37
Wang L, Menendez P, Shojaei F, Li L, Mazurier F, Dick JE et al (2005) Generation of hematopoietic repopulating cells from human embryonic stem cells independent of ectopic HOXB4 expression. J Exp Med 201(10):1603–1614
Ramos-Mejia V, Navarro-Montero O, Ayllon V, Bueno C, Romero T, Real PJ et al (2014) HOXA9 promotes hematopoietic commitment of human embryonic stem cells. Blood 124(20):3065–3075
Dou DR, Calvanese V, Sierra MI, Nguyen AT, Minasian A, Saarikoski P et al (2016) Medial HOXA genes demarcate haematopoietic stem cell fate during human development. Nat Cell Biol 18(6):595–606
Marshall H, Morrison A, Studer M, Popperl H, Krumlauf R (1996) Retinoids and hox genes. FASEB J 10(9):969–978
Chanda B, Ditadi A, Iscove NN, Keller G (2013) Retinoic acid signaling is essential for embryonic hematopoietic stem cell development. Cell 155(1):215–227
Doulatov S, Vo LT, Chou SS, Kim PG, Arora N, Li H et al (2013) Induction of multipotential hematopoietic progenitors from human pluripotent stem cells via respecification of lineage-restricted precursors. Cell Stem Cell 13(4):459–470
Sugimura R, Jha DK, Han A, Soria-Valles C, da Rocha EL, Lu YF et al (2017) Haematopoietic stem and progenitor cells from human pluripotent stem cells. Nature 545(7655):432–438
Tan YT, Ye L, Xie F, Beyer AI, Muench MO, Wang J et al (2018) Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor. Proc Natl Acad Sci U S A 115(9):2180–2185
Sanjuan-Pla A, Bueno C, Prieto C, Acha P, Stam RW, Marschalek R et al (2015) Revisiting the biology of infant t(4;11)/MLL-AF4+ B-cell acute lymphoblastic leukemia. Blood 126(25):2676–2685
Cudennec C, Nicolas JF (1977) Blood formation in a clonal cell line of mouse teratocarcinoma. J Embryol Exp Morphol 38:203–210
Cudennec CA, Johnson GR (1981) Presence of multipotential hemopoietic cells in teratocarcinoma cultures. J Embryol Exp Morphol 61:51–59
Cudennec CA, Salaun J (1979) Definitive red blood cell differentiation in a clonal line of mouse teratocarcinoma cultured in vivo in the chick embryo. Cell Differ 8(2):75–82
Amabile G, Welner RS, Nombela-Arrieta C, D'Alise AM, Di Ruscio A, Ebralidze AK et al (2013) In vivo generation of transplantable human hematopoietic cells from induced pluripotent stem cells. Blood 121(8):1255–1264
Suzuki N, Yamazaki S, Yamaguchi T, Okabe M, Masaki H, Takaki S et al (2013) Generation of engraftable hematopoietic stem cells from induced pluripotent stem cells by way of teratoma formation. Mol Ther 21(7):1424–1431
Tsukada M, Ota Y, Wilkinson AC, Becker HJ, Osato M, Nakauchi H et al (2017) In vivo generation of engraftable murine hematopoietic stem cells by Gfi1b, c-Fos, and Gata2 overexpression within teratoma. Stem Cell Reports 9(4):1024–1033
Pereira CF, Chang B, Qiu J, Niu X, Papatsenko D, Hendry CE et al (2013) Induction of a hemogenic program in mouse fibroblasts. Cell Stem Cell 13(2):205–218
Batta K, Florkowska M, Kouskoff V, Lacaud G (2014) Direct reprogramming of murine fibroblasts to hematopoietic progenitor cells. Cell Rep 9(5):1871–1884
Cheng H, Ang HY, AEF C, Li P, Fang HT, Liu TM et al (2016) Reprogramming mouse fibroblasts into engraftable myeloerythroid and lymphoid progenitors. Nat Commun 7:13396
Sandler VM, Lis R, Liu Y, Kedem A, James D, Elemento O et al (2014) Reprogramming human endothelial cells to haematopoietic cells requires vascular induction. Nature 511(7509):312–318
Lis R, Karrasch CC, Poulos MG, Kunar B, Redmond D, Duran JGB et al (2017) Conversion of adult endothelium to immunocompetent haematopoietic stem cells. Nature 545(7655):439–445
Cosgun KN, Rahmig S, Mende N, Reinke S, Hauber I, Schafer C et al (2014) Kit regulates HSC engraftment across the human-mouse species barrier. Cell Stem Cell 15(2):227–238
McIntosh BE, Brown ME, Duffin BM, Maufort JP, Vereide DT, Slukvin II et al (2015) Nonirradiated NOD,B6.SCID Il2rgamma−/− Kit(W41/W41) (NBSGW) mice support multilineage engraftment of human hematopoietic cells. Stem Cell Reports. 4(2):171–180
Yurino A, Takenaka K, Yamauchi T, Nunomura T, Uehara Y, Jinnouchi F et al (2016) Enhanced reconstitution of human erythropoiesis and thrombopoiesis in an immunodeficient mouse model with kit(Wv) mutations. Stem Cell Reports. 7(3):425–438
Wunderlich M, Chou FS, Link KA, Mizukawa B, Perry RL, Carroll M et al (2010) AML xenograft efficiency is significantly improved in NOD/SCID-IL2RG mice constitutively expressing human SCF, GM-CSF and IL-3. Leukemia 24(10):1785–1788
Rongvaux A, Willinger T, Martinek J, Strowig T, Gearty SV, Teichmann LL et al (2014) Development and function of human innate immune cells in a humanized mouse model. Nat Biotechnol 32(4):364–372
Lan P, Tonomura N, Shimizu A, Wang S, Yang YG (2006) Reconstitution of a functional human immune system in immunodeficient mice through combined human fetal thymus/liver and CD34+ cell transplantation. Blood 108(2):487–492
Melkus MW, Estes JD, Padgett-Thomas A, Gatlin J, Denton PW, Othieno FA et al (2006) Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. Nat Med 12(11):1316–1322
Sun X, Xu J, Lu H, Liu W, Miao Z, Sui X et al (2013) Directed differentiation of human embryonic stem cells into thymic epithelial progenitor-like cells reconstitutes the thymic microenvironment in vivo. Cell Stem Cell 13(2):230–236
Parent AV, Russ HA, Khan IS, LaFlam TN, Metzger TC, Anderson MS et al (2013) Generation of functional thymic epithelium from human embryonic stem cells that supports host T cell development. Cell Stem Cell 13(2):219–229
Acknowledgments
This work was supported by The Jackson Laboratory. The author thanks William Skarnes for thoughtful reading and editing of the manuscript and apologizes to authors whose papers could not be cited in this review owing to space limitations.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Oguro, H. (2019). Generation of Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells. In: Kaneko, S. (eds) In Vitro Differentiation of T-Cells. Methods in Molecular Biology, vol 2048. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9728-2_19
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9728-2_19
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-9727-5
Online ISBN: 978-1-4939-9728-2
eBook Packages: Springer Protocols